XNK broadens its pipeline with bladder cancer study ...Middle East

STOCKHOLM, June 28, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it is initiating a program targeting urothelial cancer, the most common form of bladder cancer. This is the first project where XNK's proprietary technology platform of natural killer (NK) cell therapies...

Read More Details
Finally We wish PressBee provided you with enough information of ( XNK broadens its pipeline with bladder cancer study )

Also on site :

• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Friday, July 4
• Ministry of Economy Establishes the Syrian-Canadian Business Council
• Beloved ‘60s Icon, 75, Dazzles London Event in Chic Pink Blazer and High-Top Sneakers